TY  - JOUR
AU  - Berciano-Guerrero, Miguel-Ángel
PY  - 2022
DO  - 10.1002/cam4.5108
UR  - http://hdl.handle.net/10668/21285
T2  - Cancer medicine
AB  - Locoregional recurrence of differentiated thyroid cancer (DTC) occurs in 20% of thyroid cancer patients. Currently, there are many strategies for management of locoregional recurrence of DTC that lead to local control of the disease. The introduction...
LA  - en
KW  - enolization
KW  - lenvatinib
KW  - radiotherapy
KW  - surgery
KW  - Adenocarcinoma
KW  - Antineoplastic Agents
KW  - Humans
KW  - Iodine Radioisotopes
KW  - Neoplasm Recurrence, Local
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Quinolines
KW  - Thyroid Neoplasms
TI  - Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine-refractory differentiated thyroid cancer.
TY  - research article
VL  - 11 Suppl 1
ER  -